Illinois 104th General Assembly Status: Introduced 23 D cosponsors

HR0158      — AUDIT-340B PROGRAM

Last action — Rule 19(b) / Re-referred to Rules Committee

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced February 26, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

The bill mandates a comprehensive investigation of the 340B Drug Pricing Program in Illinois.

This legislation directs the Auditor General to investigate how covered entities in Illinois utilize the 340B Drug Pricing Program, including profits, costs, and effects on patients. It aims to assess practices related to drug pricing and their impact on state health programs.

What this means for you
  • Families: Families may experience changes in drug pricing at pharmacies as the audit evaluates how discounts are passed on to patients.
  • Healthcare: This means increased scrutiny of the financial practices of healthcare entities involved in the 340B program, potentially affecting drug pricing and access.

Summary

Directs the Auditor General to conduct a comprehensive investigation of the utilization of the 340B Drug Pricing Program by covered entities within Illinois to assess the amount of 340B profit, defined as total patient and payer reimbursement less the total 340B acquisition cost, generated by 340B covered entities from both self-administered and physician-administered drugs, the amount spent on third party administrators for the management of the 340B Program, the amount going to pharmacy benefit managers (PBM) in contract pharmacy arrangements, the amount going to contract pharmacies, whether covered entities maintain title to 340B drugs in contract pharmacy locations, the average mark-up imposed by covered entities on 340B priced drugs, and the extent to which 340B entities pass 340B discounts to vulnerable patients at the point of sale for both in-house and contracted pharmacies and to also examine the impact of these practices on state health programs, such as Medicaid and the State Employees Group Insurance Program, and to make recommendations for improvement.

Bill Text

We don't have the full text on file for this bill yet.

Read HR0158 on the official Illinois source →

Action History

  1. Rule 19(b) / Re-referred to Rules Committee

  2. Assigned to Executive Committee

  3. Added Co-Sponsor Rep. Katie Stuart

  4. Added Co-Sponsor Rep. Martha Deuter

  5. Added Co-Sponsor Rep. Harry Benton

  6. Added Co-Sponsor Rep. Sonya M. Harper

  7. Added Co-Sponsor Rep. Jawaharial Williams

  8. Added Co-Sponsor Rep. Justin Slaughter

  9. Added Co-Sponsor Rep. Nicholas K. Smith

  10. Added Co-Sponsor Rep. Debbie Meyers-Martin

  11. Added Co-Sponsor Rep. Carol Ammons

  12. Added Co-Sponsor Rep. Michael Crawford

  13. Added Co-Sponsor Rep. Kimberly Du Buclet

  14. Added Co-Sponsor Rep. Jehan Gordon-Booth

  15. Added Co-Sponsor Rep. William "Will" Davis

  16. Added Co-Sponsor Rep. La Shawn K. Ford

  17. Added Co-Sponsor Rep. Thaddeus Jones

  18. Added Co-Sponsor Rep. Maurice A. West, II

  19. Added Co-Sponsor Rep. Yolonda Morris

  20. Added Co-Sponsor Rep. Mary Beth Canty

  21. Added Co-Sponsor Rep. Lisa Davis

  22. Added Co-Sponsor Rep. Camille Y. Lilly

  23. Added Co-Sponsor Rep. Kam Buckner

  24. Added Chief Co-Sponsor Rep. Rita Mayfield

  25. Rule 19(b) / Re-referred to Rules Committee

  26. Assigned to Human Services Committee

  27. Referred to Rules Committee

  28. Filed with the Clerk by Rep. Curtis J. Tarver, II

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 22 co-sponsors · 160 not signed on

Sponsors (1)

Co-sponsors (22)

Not signed on (160)

160 members have not signed on to this bill.

Show all 160 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR0158      do?
Directs the Auditor General to conduct a comprehensive investigation of the utilization of the 340B Drug Pricing Program by covered entities within Illinois to assess the amount of 340B profit, defined as total patient and payer reimbursement less the total 340B acquisition cost, generated by 340B covered entities from both self-administered and physician-administered drugs, the amount spent on third party administrators for the management of the 340B Program, the amount going to pharmacy benefit managers (PBM) in contract pharmacy arrangements, the amount going to contract pharmacies, whether covered entities maintain title to 340B drugs in contract pharmacy locations, the average mark-up imposed by covered entities on 340B priced drugs, and the extent to which 340B entities pass 340B discounts to vulnerable patients at the point of sale for both in-house and contracted pharmacies and to also examine the impact of these practices on state health programs, such as Medicaid and the State Employees Group Insurance Program, and to make recommendations for improvement.
Who sponsors HR0158     ?
HR0158      is sponsored by Curtis J. Tarver, II (Democrat), Rita Mayfield (Democrat), Kam Buckner (Democrat), Camille Y. Lilly (Democrat), Lisa Davis (Democrat), Mary Beth Canty (Democrat), Yolonda Morris (Democrat), Maurice A. West, II (Democrat), Thaddeus Jones (Democrat), La Shawn K. Ford (Democrat), William "Will" Davis (Democrat), Jehan Gordon-Booth (Democrat), Kimberly Du Buclet (Democrat), Michael Crawford (Democrat), Carol Ammons (Democrat), Debbie Meyers-Martin (Democrat), Nicholas K. Smith (Democrat), Justin Slaughter (Democrat), Jawaharial Williams (Democrat), Sonya M. Harper (Democrat), Harry Benton (Democrat), Martha Deuter (Democrat), and Katie Stuart (Democrat).
What is the current status of HR0158     ?
This bill has been introduced in the House. Introduced February 26, 2025. It must pass committee before a floor vote.
Where can I track HR0158     ?
Track HR0158      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR0158     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR0158     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →